Cascade Financial Partners »

Fibrobiologics shares owned by Cascade Financial Partners

Quarter-by-quarter ownership of Fibrobiologics (FBLG) shares owned by Cascade Financial Partners from 13F filings

Historical chart of Cascade Financial Partners investment in Fibrobiologics

Tip: Access up to 7 years of quarterly data

All positions including Fibrobiologics held by Cascade Financial Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Fibrobiologics by Cascade Financial Partners

Quarter filed Position value Share count Share price at filing
2024-09-30 $872k 303k 2.88
2024-06-30 $1.6M 315k 4.99

More positions owned by Cascade Financial Partners

Eli Lilly & Co. (LLY)
Apple (AAPL)
Vanguard Tax-managed Fds Van Ftse Dev Mkt (VEA)
Ishares Tr Core S&p500 Etf (IVV)
Pepsi (PEP)
PerkinElmer (RVTY)
Vanguard Index Fds Total Stk Mkt (VTI)
Ishares Core Msci Emkt (IEMG)
Amazon (AMZN)
NVIDIA Corporation (NVDA)
Wisdomtree Tr Intl Lrgcap Dv (DOL)
Spdr Ser Tr Portfolio S&p400 (SPMD)
Vanguard World Mega Grwth Ind (MGK)
Spdr Index Shs Fds Portfolio Devlpd (SPDW)
Vanguard Specialized Funds Div App Etf (VIG)

View all positions for Cascade Financial Partners

Top funds holding Fibrobiologics

BlackRock
State Street Corporation
Geode Capital Management
Cascade Financial Partners
Vanguard Group
Requisite Capital Management
American Institute for Advanced Investment Management
Bank of America Corporation
Bank of New York Mellon
Charles Schwab Investment Management
RMR Wealth Builders
Concurrent Investment Advisors
Nuveen Asset Management
ERn Financial
Ethos Financial Group

View all funds holding Fibrobiologics